Tonsillectomies and Adenotonsillectomies--Will the Debate Never Be Over?
| Autor: | J. B. Rosefsky, J. L. Paradise, C. D. Bluestone, H. E. Rockette |
|---|---|
| Rok vydání: | 2003 |
| Předmět: |
Pediatrics
medicine.medical_specialty business.industry medicine.medical_treatment Incidence (epidemiology) Adenoid Pharyngitis Surgery Tonsillectomy Clinical trial Otitis medicine.anatomical_structure Cervical lymphadenopathy Tonsil Pediatrics Perinatology and Child Health Medicine medicine.symptom business |
| Zdroj: | PEDIATRICS. 112:205-205 |
| ISSN: | 1098-4275 0031-4005 |
| Popis: | To the Editor .— The article by Doctors Paradise, Bluestone, and colleagues,1 which discourages tonsillectomies and adenotonsillectomies (T&As) yet again, is commendable for making readers think about criteria and outcome. But insufficient data and loose criteria make it difficult to evaluate pre- versus postsurgery study groups, or versus control patients. As a concatenation of partial sets of observation and data, versus controls, the clinical trials studied: 1. otitis media in children 2. “obstructing adenoids” (and persistent mouth-breathing?) 3. group A β-hemolytic streptococcal infection in children with obstructing adenoids, or with “recurrent or persistent otitis media” 4. culture-positive β streptococcal pharyngitis in children postoperative T&A or tonsillectomy alone 5. tonsil, adenoid, or pharyngeal infection, and maybe cervical lymphadenopathy, regardless of etiologic agent, in all enrollees. Numbers 1, 2 and 3 above are contained within the “2-way trial.” Readers would learn more if enrollment culture data and postoperative surveillance regarding otitis media and nasal passage obstruction were provided. Number 4 is incomplete, lacking enrollment incidence of culture-positive β streptococcal infection for the 3-way trial. With … |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|